# FDA Inspection 1305570 - Department of Defense - Navy - March 04, 2026

Source: https://www.keypedia.com/records/fda_inspections/department-of-defense-navy/b762dab4-2625-4da0-b8ae-9ae8ddc35d97
Source feed: FDA_Inspections

> FDA Inspection 1305570 for Department of Defense - Navy on March 04, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1305570
- Company Name: Department of Defense - Navy
- Inspection Date: 2026-03-04
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: San Francisco District Office

## Related Documents

- [FDA Inspection 1204978 - 2023-04-20](https://www.keypedia.com/records/fda_inspections/department-of-defense-navy/e6740fcd-ac3b-4882-b4d1-79debcab5522)
- [FDA Inspection 1093450 - 2019-05-16](https://www.keypedia.com/records/fda_inspections/department-of-defense-navy/b586a948-f57f-437c-9d43-efddd6b7bdee)
- [FDA Inspection 986414 - 2016-09-16](https://www.keypedia.com/records/fda_inspections/department-of-defense-navy/58dbdf8f-57c9-40b7-a171-ce4386c03262)
- [FDA Inspection 841461 - 2013-06-28](https://www.keypedia.com/records/fda_inspections/department-of-defense-navy/45c85e4e-e4b5-4a77-b8b2-375757dd350e)
- [FDA Inspection 745751 - 2011-08-30](https://www.keypedia.com/records/fda_inspections/department-of-defense-navy/ade3f3df-7f70-41c1-8eaf-5692520409d6)

Company: https://www.keypedia.com/companies/department-of-defense-navy/3d5371bb-4187-4b51-a51a-6c13f8806f47

Office: https://www.keypedia.com/offices/san-francisco-district-office/6f838e9c-aae1-4665-9c46-a51d43be02df